CWA Asset Management »

Fibrobiologics shares owned by CWA Asset Management

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by CWA Asset Management from 13F filings

Historical chart of CWA Asset Management investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by CWA Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by CWA Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.5k 10k 0.55

More positions owned by CWA Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Capitol Ser Tr Sterling Cap Enh (SCEC)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Orla Mining LTD New F (ORLA)
Costco Wholesale Corporation (COST)
Franco-Nevada Corporation (FNV)

View all positions for CWA Asset Management

Top funds holding Fibrobiologics

Vanguard Group
Yorkville Advisors Global
Millennium Management
BlackRock
Landscape Capital Management
Gts Securities
Cascade Financial Partners
Geode Capital Management
Citadel Advisors
HPM Partners
State Street Corporation
Optivise Advisory Services
Requisite Capital Management
Wiley Bros.-aintree Capital
American Institute for Advanced Investment Management

View all funds holding Fibrobiologics